Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment

In late December 2019, an initial outbreak of a mysterious pneumonia characterized by fever, dry cough, fatigue, and occasional gastrointestinal symptoms was reported in a seafood wholesale wet market in Wuhan involving approximately 66% of the staff.1 Over the next few months, the outbreak resulted in the spread to 213 countries, affecting 11.5 million people with an estimated mortality rate of 3.4%.2 It is the largest and most severe pandemic since the 1918 influenza pandemic.3 The first case was reported in the Philippines on January 30th, with its first local transmission documented on March 7.4 KCI Citation Count: 1